IDXX FY 2025 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

FY 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$4.3B+10.4% YoY

Gross Profit

$2.7B61.8% margin

Operating Income

$1.4B31.6% margin

Net Income

$1.1B24.6% margin

EPS (Diluted)

$13.08

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$1.1B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$1.7B

Stockholders' Equity

$1.6B

Cash & Equivalents

$180M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.3B	$3.9B	+10.4%
Gross Profit	$2.7B	$2.4B	+11.8%
Operating Income	$1.4B	$1.1B	+20.5%
Net Income	$1.1B	$888M	+19.3%